BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Report Library

All Reports
Datamonitor Healthcare Infectious Diseases Forecast: HIV Pre-Exposure Prophylaxis (PrEP)

December 18, 2020

The HIV prevention market will more than triple over the 2020–29 forecast period, with sales in the US, Japan, and five major European markets (France, Germany, Italy, Spain, and the UK) growing from $2.8bn to $9.7bn at a compound annual growth rate (CAGR) of 14.7%. This growth will be driven by continued penetration of the at-risk population and a diversification of approved therapies available for HIV prevention.

This Datamonitor Healthcare report contains a Patient-Based Forecast module.

Indications Covered: HIV Prevention
Back to the top Back to the top